DNA-encoded chemical libraries (DELs) represent a versatile and powerful technology platform for the discovery of small-molecule ligands to protein targets of biological and pharmaceutical interest. DELs are collections of molecules, individually coupled to distinctive DNA tags serving as amplifiable identification barcodes.
The global market for DNA-encoded Chemical Libraries (DEL) was estimated to be worth US$ 184 million in 2023 and is forecast to a readjusted size of US$ 338.2 million by 2030 with a CAGR of 9.8% during the forecast period 2024-2030
North American market for DNA-encoded Chemical Libraries (DEL) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DNA-encoded Chemical Libraries (DEL) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for DNA-encoded Chemical Libraries (DEL) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of DNA-encoded Chemical Libraries (DEL) include HotSpot Therapeutics, X-Chem, Amgen, Life Chemicals, Elsevier, NovAliX, BOC Sciences, DECLTechnology and Serengen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA-encoded Chemical Libraries (DEL), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA-encoded Chemical Libraries (DEL) by region & country, by Type, and by Application.
The DNA-encoded Chemical Libraries (DEL) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA-encoded Chemical Libraries (DEL).
麻豆原创 Segmentation
By Company
HotSpot Therapeutics
X-Chem
Amgen
Life Chemicals
Elsevier
NovAliX
BOC Sciences
DECLTechnology
Serengen
BioDuro-Sundia
Novartis
DyNAbind
HitGen
PharmaBlock Sciences
WuXi AppTec
GenScript
Pharmaron
Segment by Type:
Single-pharmacophore
Dual-pharmacophore
Segment by Application
Pharmaceutical and Biotechnology Companies
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA-encoded Chemical Libraries (DEL) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of DNA-encoded Chemical Libraries (DEL) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of DNA-encoded Chemical Libraries (DEL) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 DNA-encoded Chemical Libraries (DEL) Product Introduction
1.2 Global DNA-encoded Chemical Libraries (DEL) 麻豆原创 Size Forecast
1.3 DNA-encoded Chemical Libraries (DEL) 麻豆原创 Trends & Drivers
1.3.1 DNA-encoded Chemical Libraries (DEL) Industry Trends
1.3.2 DNA-encoded Chemical Libraries (DEL) 麻豆原创 Drivers & Opportunity
1.3.3 DNA-encoded Chemical Libraries (DEL) 麻豆原创 Challenges
1.3.4 DNA-encoded Chemical Libraries (DEL) 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA-encoded Chemical Libraries (DEL) Players Revenue Ranking (2023)
2.2 Global DNA-encoded Chemical Libraries (DEL) Revenue by Company (2019-2024)
2.3 Key Companies DNA-encoded Chemical Libraries (DEL) Manufacturing Base Distribution and Headquarters
2.4 Key Companies DNA-encoded Chemical Libraries (DEL) Product Offered
2.5 Key Companies Time to Begin Mass Production of DNA-encoded Chemical Libraries (DEL)
2.6 DNA-encoded Chemical Libraries (DEL) 麻豆原创 Competitive Analysis
2.6.1 DNA-encoded Chemical Libraries (DEL) 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by DNA-encoded Chemical Libraries (DEL) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA-encoded Chemical Libraries (DEL) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single-pharmacophore
3.1.2 Dual-pharmacophore
3.2 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Type
3.2.1 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global DNA-encoded Chemical Libraries (DEL) Sales Value, by Type (2019-2030)
3.2.3 Global DNA-encoded Chemical Libraries (DEL) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology Companies
4.1.2 Research Laboratories
4.2 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Application
4.2.1 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global DNA-encoded Chemical Libraries (DEL) Sales Value, by Application (2019-2030)
4.2.3 Global DNA-encoded Chemical Libraries (DEL) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Region
5.1.1 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Region (2019-2024)
5.1.3 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Region (2025-2030)
5.1.4 Global DNA-encoded Chemical Libraries (DEL) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
5.2.2 North America DNA-encoded Chemical Libraries (DEL) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
5.3.2 Europe DNA-encoded Chemical Libraries (DEL) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
5.4.2 Asia Pacific DNA-encoded Chemical Libraries (DEL) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
5.5.2 South America DNA-encoded Chemical Libraries (DEL) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
5.6.2 Middle East & Africa DNA-encoded Chemical Libraries (DEL) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA-encoded Chemical Libraries (DEL) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions DNA-encoded Chemical Libraries (DEL) Sales Value
6.3 United States
6.3.1 United States DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.3.2 United States DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.4.2 Europe DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.5.2 China DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.5.3 China DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.6.2 Japan DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.7.2 South Korea DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.8.2 Southeast Asia DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India DNA-encoded Chemical Libraries (DEL) Sales Value, 2019-2030
6.9.2 India DNA-encoded Chemical Libraries (DEL) Sales Value by Type (%), 2023 VS 2030
6.9.3 India DNA-encoded Chemical Libraries (DEL) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 HotSpot Therapeutics
7.1.1 HotSpot Therapeutics Profile
7.1.2 HotSpot Therapeutics Main Business
7.1.3 HotSpot Therapeutics DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.1.4 HotSpot Therapeutics DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.1.5 HotSpot Therapeutics Recent Developments
7.2 X-Chem
7.2.1 X-Chem Profile
7.2.2 X-Chem Main Business
7.2.3 X-Chem DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.2.4 X-Chem DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.2.5 X-Chem Recent Developments
7.3 Amgen
7.3.1 Amgen Profile
7.3.2 Amgen Main Business
7.3.3 Amgen DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.3.4 Amgen DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.3.5 Life Chemicals Recent Developments
7.4 Life Chemicals
7.4.1 Life Chemicals Profile
7.4.2 Life Chemicals Main Business
7.4.3 Life Chemicals DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.4.4 Life Chemicals DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.4.5 Life Chemicals Recent Developments
7.5 Elsevier
7.5.1 Elsevier Profile
7.5.2 Elsevier Main Business
7.5.3 Elsevier DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.5.4 Elsevier DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.5.5 Elsevier Recent Developments
7.6 NovAliX
7.6.1 NovAliX Profile
7.6.2 NovAliX Main Business
7.6.3 NovAliX DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.6.4 NovAliX DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.6.5 NovAliX Recent Developments
7.7 BOC Sciences
7.7.1 BOC Sciences Profile
7.7.2 BOC Sciences Main Business
7.7.3 BOC Sciences DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.7.4 BOC Sciences DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.7.5 BOC Sciences Recent Developments
7.8 DECLTechnology
7.8.1 DECLTechnology Profile
7.8.2 DECLTechnology Main Business
7.8.3 DECLTechnology DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.8.4 DECLTechnology DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.8.5 DECLTechnology Recent Developments
7.9 Serengen
7.9.1 Serengen Profile
7.9.2 Serengen Main Business
7.9.3 Serengen DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.9.4 Serengen DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.9.5 Serengen Recent Developments
7.10 BioDuro-Sundia
7.10.1 BioDuro-Sundia Profile
7.10.2 BioDuro-Sundia Main Business
7.10.3 BioDuro-Sundia DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.10.4 BioDuro-Sundia DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.10.5 BioDuro-Sundia Recent Developments
7.11 Novartis
7.11.1 Novartis Profile
7.11.2 Novartis Main Business
7.11.3 Novartis DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.11.4 Novartis DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.11.5 Novartis Recent Developments
7.12 DyNAbind
7.12.1 DyNAbind Profile
7.12.2 DyNAbind Main Business
7.12.3 DyNAbind DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.12.4 DyNAbind DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.12.5 DyNAbind Recent Developments
7.13 HitGen
7.13.1 HitGen Profile
7.13.2 HitGen Main Business
7.13.3 HitGen DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.13.4 HitGen DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.13.5 HitGen Recent Developments
7.14 PharmaBlock Sciences
7.14.1 PharmaBlock Sciences Profile
7.14.2 PharmaBlock Sciences Main Business
7.14.3 PharmaBlock Sciences DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.14.4 PharmaBlock Sciences DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.14.5 PharmaBlock Sciences Recent Developments
7.15 WuXi AppTec
7.15.1 WuXi AppTec Profile
7.15.2 WuXi AppTec Main Business
7.15.3 WuXi AppTec DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.15.4 WuXi AppTec DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.15.5 WuXi AppTec Recent Developments
7.16 GenScript
7.16.1 GenScript Profile
7.16.2 GenScript Main Business
7.16.3 GenScript DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.16.4 GenScript DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.16.5 GenScript Recent Developments
7.17 Pharmaron
7.17.1 Pharmaron Profile
7.17.2 Pharmaron Main Business
7.17.3 Pharmaron DNA-encoded Chemical Libraries (DEL) Products, Services and Solutions
7.17.4 Pharmaron DNA-encoded Chemical Libraries (DEL) Revenue (US$ Million) & (2019-2024)
7.17.5 Pharmaron Recent Developments
8 Industry Chain Analysis
8.1 DNA-encoded Chemical Libraries (DEL) Industrial Chain
8.2 DNA-encoded Chemical Libraries (DEL) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA-encoded Chemical Libraries (DEL) Sales Model
8.5.2 Sales Channel
8.5.3 DNA-encoded Chemical Libraries (DEL) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
HotSpot Therapeutics
X-Chem
Amgen
Life Chemicals
Elsevier
NovAliX
BOC Sciences
DECLTechnology
Serengen
BioDuro-Sundia
Novartis
DyNAbind
HitGen
PharmaBlock Sciences
WuXi AppTec
GenScript
Pharmaron
听
听
*If Applicable.
